PSMA-11

CAS : 1366302-52-4

Ref. 3D-REC30252

Informations sur le produit

• Nom: PSMA-11

Description

PSMA-11 is a positron-emitting metal chelate that is used in the diagnosis of prostate cancer. It is administered as a diagnostic agent and has been shown to be clinically relevant for prostate cancer diagnosis. PSMA-11 has shown to have pharmacokinetic properties that can be retrospectively analyzed by measuring the amount of radioactivity in the patient's urine, which is indicative of the amount of PSMA-11 absorbed by the body. This biomarker can also be used for assessing the effectiveness of radiation therapy in patients with prostate cancer. PSMA-11 has been shown to bind to the human serum albumin, which may contribute to its pharmacokinetic properties. The imaging properties of PSMA-11 are still being explored but it has been found to show promise for use as a diagnostic agent in early stages of prostate cancer.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 947 g/mol
• Formule: C₄₄H₆₂N₆O₁₇
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder